Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

01 December 2007

Drug lymphocyte level: New perspective in clinical immunosuppression monitoring

A. Barbari

Ann Transplant 2008; 13(1): 43-43 :: ID: 880210

Abstract

We, like others, have shown a weak correlation between drug blood levels and clinical outcome and immune response. We have recently established that in contrast to blood levels, drug lymphocyte levels exhibit a strong association with therapeutic efficacy. This discordance is mainly related to the weak association between drug blood level and target cell content as we have reported recently. It explains the intra and inter-individual variability in therapeutic response. These variations are mainly related to both genetic and environmental parameters such as age, gender, body mass index, organ function, food, drugs interaction and availability of extra target cell binding sites. These factors seem to influence all the steps involved in the mode of action of any immunosuppressive agent, including drug absorption, metabolism, elimination, transport, extra target cell sites as well as target cell receptor expression and its binding affinity in addition to specific enzyme baseline activity. Therefore, the cellular fraction of a drug at a fixed dose is the result of the integration of out-fluxing and in-fluxing forces that are affected by both genetic and environmental parameters. Any redistribution of the drug between the different binding sites will ultimately affect its intra-cellular bioavailability and hence its bioactivity without any change in its extra-cellular bioavailability currently determined by plasma or whole blood pharmacokinetic measurements. Monitoring immunosuppression therapy at the site of action appears to be not only more clinically and immunologically relevant than whole blood or plasma level measurements since it measures the free fraction of the drug at it's effector site, but it also allows the bypass of all potential complex extra-cellular interferences with bioactivity. It is truly comparable to pharmacodynamic monitoring since the intra-cellular content of a drug strongly correlates with its biological effect. It is cost-effective and easily applicable in clinical practice and could be used for all immunosuppressive drugs. It should offer a new alternative for immunosuppressive therapy monitoring and tailoring and hence individualisation, since it allows maximal reduction in adverse side effects through dose reduction while maintaining an optimal level of immunosuppression.

Keywords: rats, laser cordectomy, Environmental parameters

0 Comments

In Press

04 Aug 2022 : Original article  

Long-Term Patency of All-in-One Sleeve Patch Graft Venoplasty in 16 Patients Who Underwent Living Donor Liv...

Ann Transplant In Press; DOI: 10.12659/AOT.936888  

22 Jul 2022 : Original article  

Diagnostic Role of Tumor Markers for Hepatocellular Carcinoma in Liver Transplantation Candidates: An Analy...

Ann Transplant In Press; DOI: 10.12659/AOT.936937  

22 Jul 2022 : Original article  

Development of a Novel Model for Predicting Postoperative Short-Term Outcome in Patients with Hepatitis B-R...

Ann Transplant In Press; DOI: 10.12659/AOT.936732  

22 Jul 2022 : Original article  

Leucine-Rich Alpha-2-Glycoprotein (LRG-1) as a Potential Kidney Injury Marker in Kidney Transplant Recipients

Ann Transplant In Press; DOI: 10.12659/AOT.936751  

Most Viewed Current Articles

26 Jan 2022 : Review article  

Recurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive Models

DOI :10.12659/AOT.934924

Ann Transplant 2022; 27:e934924

29 Dec 2021 : Original article  

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

24 Jul 2020 : Review article  

Kidney Transplantation in the Times of COVID-19 – A Literature Review

DOI :10.12659/AOT.925755

Ann Transplant 2020; 25:e925755

15 Mar 2022 : Case report  

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358